OAT
OAT (ornithine aminotransferase, also known as HOGA) is a mitochondrial pyridoxal-phosphate-dependent enzyme that catalyses the reversible interconversion of L-ornithine and 2-oxoglutarate to L-glutamate semialdehyde and L-glutamate. It sits on the pathway linking arginine and ornithine to glutamate and GABA. Browse Assay Genie's current range of OAT research reagents below, or read on for the biology behind the target.
OAT is a mitochondrial aminotransferase. It catalyses the reversible interconversion of L-ornithine and 2-oxoglutarate to L-glutamate semialdehyde and L-glutamate. According to the NCBI Gene summary, it is a key enzyme in the pathway that converts arginine and ornithine into glutamate and GABA, the major excitatory and inhibitory neurotransmitters. The reaction is classed under EC 2.6.1.13, and the enzyme acts within the mitochondrial matrix.
The OAT gene encodes a protein that belongs to the class-III pyridoxal-phosphate-dependent aminotransferase family, and HGNC places it in the transaminases gene group. Alternatively spliced transcript variants encoding different isoforms have been described. Related pseudogenes have been defined on the X chromosome, which is worth bearing in mind when designing nucleic acid based assays for the OAT gene. Mouse and rat each carry an orthologous Oat gene, so the enzyme can be studied in common rodent models.
OAT is best known for its link to disease. Mutations that result in a deficiency of this enzyme cause gyrate atrophy, an autosomal recessive eye disease. The enzyme also appears under the alias HOGA. Researchers working on amino acid metabolism, mitochondrial enzymology and neurotransmitter biosynthesis use OAT as a reference point for how ornithine and arginine metabolism connects with glutamate and GABA production. Any OAT antibody, OAT ELISA kit or OAT protein reagent should be matched to the species and application of your experiment.
OAT interconverts L-ornithine and 2-oxoglutarate with L-glutamate semialdehyde and L-glutamate, placing it at a junction of ornithine and glutamate metabolism.
The enzyme is a key step in converting arginine and ornithine into glutamate and GABA, the main excitatory and inhibitory neurotransmitters.
Loss-of-function mutations in OAT cause gyrate atrophy, an autosomal recessive eye disease, making the gene central to studies of this condition.
As a matrix-localised, pyridoxal-phosphate-dependent class-III aminotransferase, OAT is a model for studying mitochondrial transaminase function.
OAT catalyses the reversible interconversion of L-ornithine and 2-oxoglutarate to L-glutamate semialdehyde and L-glutamate. It is a key enzyme in the pathway that converts arginine and ornithine into the neurotransmitters glutamate and GABA, and it works in the mitochondrial matrix.
OAT stands for ornithine aminotransferase, and HOGA is a listed alias. UniProt names the protein as mitochondrial ornithine aminotransferase. Alternatively spliced transcript variants encoding different isoforms have been described, and related pseudogenes exist on the X chromosome.
Mutations that cause OAT deficiency lead to gyrate atrophy, an autosomal recessive eye disease. Mouse and rat both have an Oat ortholog, so rodent studies are possible. Check the datasheet of any product for its validated reactivity.
Other transaminases, amino acid metabolism enzymes and neurotransmitter pathway targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P04181; product specifications from Assay Genie datasheets.